Skip to the page

Data / Drug companies / Docusate sodium, sennosides

Docusate sodium, sennosides: 18 companies and 23 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Docusate sodium, sennosides is listed in the FDA National Drug Code Directory by 18 companies, with 23 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; capsule, liquid filled; tablet, film coated, and the newest product started marketing on August 20, 2026.

The request: Get every company that lists docusate sodium, sennosides in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
18
Products
23
Generic (ANDA) products
0 (0.0%)
Application numbers
2
Routes
Oral
Brand names
Senna S, Senna Plus, Stool Softener Laxative, HyVee Senna S, Stool Softener and Stimulant Laxative, CVS Health Stool Softener Plus Stimulant Laxative Softgel, Stool Softener Plus Laxative, Laxative and Stool Softener
openFDA record search
api.fda.gov

Companies that list docusate sodium, sennosides

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
CVS Pharmacy2tabletOver the counter monograph drugsDecember 27, 2019
Discount Drug Mart2tabletOver the counter monograph drugsJuly 20, 2021
HyVee Inc2tabletOver the counter monograph drugsAugust 20, 2026
Wal-Mart Stores Inc2tabletOver the counter monograph drugsSeptember 1, 2020
Walgreen Company2tablet; capsule, liquid filledOver the counter monograph drugsOctober 20, 2023
Amerisource Bergen1tabletOver the counter monograph drugsNovember 29, 2019
CVS Woonsocket Prescription Center, Incorporated1capsule, liquid filledOver the counter monograph drugsMarch 19, 2025
Chain Drug Marketing Association1tabletOver the counter monograph drugsOctober 30, 2019
Family Dollar (family Wellness)1tabletOver the counter monograph drugsJuly 1, 2023
Granulation Technology, Inc.1tablet, film coatedOver the counter monograph drugsJuly 29, 2025
H E B1tabletOver the counter monograph drugsFebruary 4, 2022
Magno-Humphries, Inc.1tabletOver the counter monograph drugsJanuary 24, 2020
Safeway1tabletOver the counter monograph drugsNovember 29, 2019
Sato Pharmaceutical Co., Ltd.1tabletOver the counter monograph drugsDecember 20, 2002
Shield Pharmaceuticals Corp1capsule, liquid filledOver the counter monograph drugsDecember 5, 2025
Topco Associates LLC1tabletOver the counter monograph drugsJuly 31, 2019
United Natural Foods, Inc. DBA Unfi1tabletOver the counter monograph drugsMarch 26, 2021
Walmart Inc.1tabletOver the counter monograph drugsDecember 31, 2020

Dosage forms

Dosage formProductsShare
Tablet1982.6%
Capsule, liquid filled313%
Tablet, film coated14.3%

Marketing categories

Marketing categoryProductsShare
Over the counter monograph drugs23100%

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.